We represented a health system in a dispute that arose because the software vendor was not providing the services and support required under its managed services agreement. In these negotiations, we succeeded in terminating the contract, thus avoiding more than $70 million of contractual obligations.
Client Avoids $70 Million in Contractual Obligations
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee